AAO Decisions Explorer · Free
Published AAO appeal decisions
Search the decisions the Administrative Appeals Office has published, narrow them by visa, criterion, field and year, and read our summary of each one with a link to the official PDF.

Decisions in the library
6,586
6,586 classified
Visa types
3
Years covered
2005-2026
Latest decision
Aug 31, 2026
Filters
5 decisions
Outcomes in these results
- Dismissed
- Remanded
- Sustained
- EB-2 NIWBiotech and pharmaNov 2025Dismissed
Director of facilities and engineering in pharmaceutical manufacturing seeks EB-2 NIW. SCOPS found petitioner met underlying EB-2 requirement. AAO held petitioner's proposed endeavor lacks national importance; past experience and planned mentoring insufficient to establish broader industry impact required under Dhanasar.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJun 2025Dismissed
Business development manager in pharmaceutical sector seeks EB-2 NIW. SCOPS found petitioner qualified for EB-2 and met second Dhanasar prong. AAO held first prong unmet because petitioner conflated general field importance with specific endeavor's national importance; no prospective impact directly attributable to petitioner's work.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMay 2025Dismissed
Engineer and researcher in clinical tissue engineering and transplantation seeking EB-2 advanced degree classification and national interest waiver. AAO affirmed that petitioner qualified as advanced degree professional but dismissed appeal because petitioner failed to demonstrate being well-positioned to advance proposed endeavor; education and publications insufficient without demonstrated record of success.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaApr 2025Sustained
A pharmaceutical researcher with advanced degree seeking EB-2 classification and national interest waiver for nanotechnology drug delivery research targeting cancer and HIV. AAO sustained appeal, finding all three Dhanasar prongs met: endeavor advances federal priorities, petitioner well-positioned through expertise and proven success, and waiver benefits U.S. public health.
3 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMar 2025Sustained
Biomedical engineer with advanced degree seeks EB-2 with national interest waiver to research neurodegenerative diseases. AAO sustained appeal, finding all three Dhanasar prongs met: research has substantial merit and national importance, petitioner well-positioned to advance it, and waiver would benefit United States.
3 of 3 criteria metRead →
